This page shows the latest The Competition and Markets Authority news and features for those working in and with pharma, biotech and healthcare.
The EU clearance comes after similar competition clearances in the US, Japan and other global regulatory agencies, AZ said in a statement. ... In May, the UK’s Competition and Markets Authority (CMA) announced that it was reviewing AZ’s proposed
The UK’s Competition and Markets Authority (CMA) is set to review AstraZeneca’s (AZ) planned takeover of rare diseases specialist Alexion. ... Competition clearances have also been completed in Canada, Brazil, Russia and other countries.
The US antitrust approval swiftly follows the clearance from the UK’s Competition and Markets Authority (CMA), which announced early yesterday that its investigation into the merger was complete. ... However, the antitrust authority finally concluded
the UK's Competition and Markets Authority (CMA) finally approved the deal. ... The CMA therefore found that the deal between Roche and Spark would not negatively affect competition because UK health services and patients will still have an adequate
Facing penalty for dramatic price hikes of an epilepsy drug. The UK’s competition regulator is pushing to reinstate a £90m fine for Pfizer and Flynn Pharma – quashed last year – over ... The case dates back to 2015, when the Competition and
Competition and Markets Authority (CMA) have taken their time to probe antitrust issued raised by the deal. ... The Capitol Forum report suggests that review staff are happy to accept the deal, but that senior officials at the FTC's Bureau of
More from news
Approximately 0 fully matching, plus 16 partially matching documents found.
How the CMA is tackling high prices for essential drugs. The Competition and Markets Authority (CMA) is tasked with strengthening business competition and reducing anti-competitive practices for the benefit of ... were hampering healthy competition. The
The analysts also now predict Vertex will be able to maintain its prices in both markets, rather than have to drop them slightly in the face of competition. ... could refer the company to the Competition and Markets Authority for “what appears to us to
Nordkamp took time out from judging the entries to stress the importance of technological disruption to the UK and global markets. ... The company is still reeling from its record £84.2m fine last December from the UK government’s Competition and
More from intelligence
Approximately 1 fully matching, plus 2 partially matching documents found.
For over a decade, our medical communication services have helped pharmaceutical companies optimize their brand, disease and corporate objectives. Building...